DeRoyal Industries Inc., with a 38 year history of providing high
quality products and innovative services to the healthcare industry,
announces its entry into the global orthopaedic fracture repair market.
“We are incredibly excited to offer a line of high quality,
domestically manufactured orthopaedic trauma implants,” said DeRoyal
CEO, Brian DeBusk. “In today's healthcare environment, doctors and
hospitals need access to cutting-edge technology that is also mindful of
mounting cost pressures. At DeRoyal, we have worked with our physician
partners to incorporate the aspects of both features and cost into a
product that offers an unprecedented value proposition. Our line will
continue to broaden over time as we move into every aspect of orthopedic
trauma."
Escalating implant costs, declines in provider reimbursement, and
healthcare reform on the horizon, have created an ideal environment for
DeRoyal Implants to enter the marketplace and address these issues
head-on. The focus is to create a sales model which streamlines the
supply chain, reduces the selling, general and administrative costs
associated with highly compensated medical device reps and pass those
savings directly through to its customers.
DeRoyal Implants recently launched its small fragment and large
fragment plate and screw sets. The company will continue to develop a
comprehensive line of domestically manufactured implants and
instruments, with several new product launches slated for release over
the next several months. Product development will center on implants
commonly used in high volume surgical trauma procedures. “Having
in-house manufacturing allows us to react quickly to market conditions,
directly control our quality initiatives, and expedite our product
launches,” says Travis Turley, Director of DeRoyal Implants. “We are
excited by Brian’s (DeRoyal CEO) vision and the future of DeRoyal
Implants, as we lead the charge to impact the landscape of orthopaedic
device sales and address rising concerns over healthcare costs.”